BLB&B Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,775
| Closed | -$336K | – | 253 |
|
|
2021
Q4 | $336K | Sell |
5,775
-6,982
| -55% | -$406K | 0.02% | 209 |
|
|
2021
Q3 | $766K | Sell |
12,757
-4,117
| -24% | -$247K | 0.05% | 150 |
|
|
2021
Q2 | $1.01M | Sell |
16,874
-12,500
| -43% | -$749K | 0.07% | 122 |
|
|
2021
Q1 | $1.46M | Sell |
29,374
-67,453
| -70% | -$3.35M | 0.11% | 102 |
|
|
2020
Q4 | $4.84M | Buy |
96,827
+6,858
| +8% | +$343K | 0.39% | 66 |
|
|
2020
Q3 | $4.93M | Buy |
89,969
+563
| +0.6% | +$30.9K | 0.5% | 60 |
|
|
2020
Q2 | $4.73M | Sell |
89,406
-6,412
| -7% | -$339K | 0.51% | 61 |
|
|
2020
Q1 | $4.28M | Sell |
95,818
-1,521
| -2% | -$67.9K | 0.56% | 59 |
|
|
2019
Q4 | $4.85M | Sell |
97,339
-1,730
| -2% | -$86.3K | 0.5% | 54 |
|
|
2019
Q3 | $4.42M | Sell |
99,069
-7,015
| -7% | -$313K | 0.5% | 56 |
|
|
2019
Q2 | $4.38M | Sell |
106,084
-1,500
| -1% | -$61.9K | 0.5% | 53 |
|
|
2019
Q1 | $4.35M | Buy |
107,584
+14,476
| +16% | +$585K | 0.51% | 50 |
|
|
2018
Q4 | $3.54M | Buy |
93,108
+3,862
| +4% | +$147K | 0.49% | 55 |
|
|
2018
Q3 | $3.53M | Buy |
89,246
+19,376
| +28% | +$767K | 0.44% | 63 |
|
|
2018
Q2 | $2.45M | Buy |
69,870
+10,159
| +17% | +$357K | 0.33% | 84 |
|
|
2018
Q1 | $2.09M | Buy |
59,711
+4,862
| +9% | +$170K | 0.28% | 93 |
|
|
2017
Q4 | $1.9M | Buy |
54,849
+31,388
| +134% | +$1.09M | 0.27% | 92 |
|
|
2017
Q3 | $795K | Buy |
+23,461
| New | +$795K | 0.12% | 149 |
|